Results

1–10 of 39 results for Retinitis Pigmentosa

Surgical Case Conference: Sengul Ozdek, MD, FEBO, FASRS
Sengul Ozdek, MD, FEBO, FASRS
Annual Meeting Talks
2024
One Year Follow-up in a Phase 1/2 Clinical Trial of a Gene Modifier Therapy (OCU400) for the Treatment of Retinitis Pigmentosa
Benjamin Bakall, MD, PhD
Annual Meeting Talks
2024
BCVA Analysis of Low- or High-Dose MCO-010 Optogenetic Therapy for Retinitis Pigmentosa: FIRST TIME 100-Week TOPLINE Results From a Phase 2b/3 Clinical Trial (RESTORE)
Michael A. Singer, MD
Annual Meeting Talks
2024
Subretinal AGTC-501 Gene Therapy for XLRP: 12-Month Interim Safety & Efficacy Results of the Randomized Controlled Multicenter Phase 2 Skyline Trial
Rajiv Anand, MD, FRCS, FASRS
Annual Meeting Talks
2024
Clinical Characterization of Hexokinase 1 (HK1) Mutations Causing Autosomal Dominant Pericentral Retinitis Pigmentosa
Patrick Staropoli, MD
Annual Meeting Talks
2024
Retinitis Pigmentosa Bullseye Appearing Autofluorescence
Retina Image Bank: Images of the Week
2025
Retinitis Pigmentosa with PPRPE
Vishal Agrawal, MD, FRCS,FACS,FASRS
Retina Image Bank: Images of the Week
2025
Pericentral Retinitis Pigmentosa
Mauricio Bayram-Suverza, MD
Mark E Pennesi, MD/PhD
Retina Image Bank: Images of the Week
2024
Multicenter Randomized Sham-Controlled Double-Masked Phase 2b Clinical Trial of Multi-Characteristic Opsin in Patients With Advanced Retinitis Pigmentosa
Peter K. Kaiser, MD FASRS
Annual Meeting Talks
2022
One Year Follow-Up in a Phase ½ Clinical Trial of a Gene Modifier Therapy (OCU400) for the Treatment of Retinitis Pigmentosa
Benjamin Bakall, MD, PhD
Updates from the Field
2024